Clinical Prediction of Parkinson's Disease: Planning for the Age of Neuroprotection

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.2009.174748
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Neuroprotection by a Mitochondria-Targeted Drug in a Parkinson's Disease Model

Free Radical Biology and Medicine
BiochemistryPhysiology
2010English

Role of the Prolyl Isomerase Pin1 in the Pathogenesis of Parkinson's Disease and Neuroprotection by Novel Targeted Compounds in Pre-Clinical Animal Models of the Disease

English

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease

Frontiers in Neurology
Neurology
2018English

A Spirulina-Enhanced Diet Provides Neuroprotection in an Α-Synuclein Model of Parkinson's Disease

PLoS ONE
Multidisciplinary
2012English

Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2010English

Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2018English

Enrichment of Minor Alleles of Common SNPs and Improved Risk Prediction for Parkinson's Disease

PLoS ONE
Multidisciplinary
2015English

Evolving Classifiers to Inform Clinical Assessment of Parkinson's Disease

2013English

The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy